Plasma sphingolipids and risk of cardiovascular diseases: a large-scale lipidomic analysis

CerS1-Derived C18:0 Ceramide in Skeletal Muscle Promotes Obesity-Induced Insulin Resistance

(2019) Sarah M. Turpin-Nolan et al.   Cell Reports

The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach

(2019) Suryaprakash Raichur et al.   Molecular Metabolism

Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk

(2019) Rozenn N. Lemaitre et al.   Circulation-Heart Failure

ST-segment elevation myocardial infarction with non-chest pain presentation at the Emergency Department: Insights from the Singapore Myocardial Infarction Registry

(2019) Jeremy Zhenwen Pong et al.   Internal and Emergency Medicine

Sphingolipidomics analysis of large clinical cohorts. Part 1: Technical notes and practical considerations

(2018) Wee Siong Chew et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cohort Profile: The Singapore Multi-Ethnic Cohort (MEC) study

(2018) Kristin Hui Xian Tan et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

The Ceramide Ratio: A Predictor of Cardiometabolic Risk

(2018) Trevor S. Tippetts et al.   JOURNAL OF LIPID RESEARCH

Ceramide Remodeling and Risk of Cardiovascular Events and Mortality

(2018) Linda R. Peterson et al.   Journal of the American Heart Association

Plasma glucosylceramides and cardiovascular risk in incident hemodialysis patients

(2018) Mark M. Mitsnefes et al.   Journal of Clinical Lipidology

Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease

(2017) Amin Polzin et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Sphingolipids and Lipoproteins in Health and Metabolic Disorders

(2017) Jahangir Iqbal et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol

(2016) Reijo Laaksonen et al.   EUROPEAN HEART JOURNAL

Improved batch correction in untargeted MS-based metabolomics

(2016) Ron Wehrens et al.   Metabolomics

Large-scale untargeted LC-MS metabolomics data correction using between-batch feature alignment and cluster-based within-batch signal intensity drift correction

(2016) Carl Brunius et al.   Metabolomics

Discovering and validating between-subject variations in plasma lipids in healthy subjects

(2016) Husna Begum et al.   Scientific Reports

Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE−/− mice

(2015) Sumita Mishra et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The effect of altered sphingolipid acyl chain length on various disease models

(2015) Woo-Jae Park et al.   BIOLOGICAL CHEMISTRY

Sphingolipids in cardiovascular diseases and metabolic disorders

(2015) Sonia Borodzicz et al.   Lipids in Health and Disease

Trends in Stroke Incidence and 28-Day Case Fatality in a Nationwide Stroke Registry of a Multiethnic Asian Population

(2015) Chuen Seng Tan et al.   STROKE

Lipidomic “Deep Profiling”: An Enhanced Workflow to Reveal New Molecular Species of Signaling Lipids

(2014) Pradeep Narayanaswamy et al.   ANALYTICAL CHEMISTRY

Inhibition of Glycosphingolipid Synthesis Ameliorates Atherosclerosis and Arterial Stiffness in Apolipoprotein E −/− Mice and Rabbits Fed a High-Fat and -Cholesterol Diet

(2014) Subroto Chatterjee et al.   CIRCULATION

Human Plasma Lipidome Is Pleiotropically Associated With Cardiovascular Risk Factors and Death

(2014) C. Bellis et al.   Circulation-Cardiovascular Genetics

Lipidome of Atherosclerotic Plaques from Hypercholesterolemic Rabbits

(2014) Lazar Bojic et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Glycerophospholipid and Sphingolipid Species and Mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study

(2014) Alexander Sigruener et al.   PLoS One

Adenovirus-mediated sphingomyelin synthase 2 increases atherosclerotic lesions in ApoE KO mice

(2013) Xiaogang Wang et al.   Lipids in Health and Disease

Biological functions of sphingomyelins

(2013) J. Peter Slotte   PROGRESS IN LIPID RESEARCH

Impact of Sphingomyelin Synthase 1 Deficiency on Sphingolipid Metabolism and Atherosclerosis in Mice

(2012) Zhiqiang Li et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Role of sulfatide in normal and pathological cells and tissues

(2012) Tadanobu Takahashi et al.   JOURNAL OF LIPID RESEARCH

Chain length-specific properties of ceramides

(2011) Sabine Grösch et al.   PROGRESS IN LIPID RESEARCH

Platelets in atherosclerosis

(2011) Philipp von Hundelshausen et al.   THROMBOSIS AND HAEMOSTASIS

Association of Plasma Sphingomyelin Levels and Incident Coronary Heart Disease Events in an Adult Population

(2009) Joseph Yeboah et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection

(2009) K. Sattler et al.   CARDIOVASCULAR RESEARCH

Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology

(2009) Catherine Pavoine et al.   CARDIOVASCULAR RESEARCH

Macrophage Sphingomyelin Synthase 2 Deficiency Decreases Atherosclerosis in Mice

(2009) Jing Liu et al.   CIRCULATION RESEARCH

Sphingomyelin metabolism at the plasma membrane: Implications for bioactive sphingolipids

(2009) Delphine Milhas et al.   FEBS LETTERS

The SPTLC3 Subunit of Serine Palmitoyltransferase Generates Short Chain Sphingoid Bases

(2009) Thorsten Hornemann et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The sphingolipid salvage pathway in ceramide metabolism and signaling

(2008) Kazuyuki Kitatani et al.   CELLULAR SIGNALLING

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

(2008) Sekar Kathiresan et al.   NATURE GENETICS

Principles of bioactive lipid signalling: lessons from sphingolipids

(2008) Yusuf A. Hannun et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY